| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.094 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.22 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |